Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
affirmed, andCounty, andRanbaxy, Andrx, asIn, beginning, Biaxin®XL, Boehringer, CEO, Chair, charter, Chautaugua, Chenango, Colorado, committee, concerningin, conditionally, consent, contingent, control, decide, decree, dependent, diluted, EAS, Erie, fiscal, forHumira, gave, half, Impax, implement, Ingelheim, interim, Klacid, lesser, lift, model, Montgomery, ofHumira, ofHytrin, ofLupron, ofMobic, ofSimilac, ofSynthroid, Onondaga, opted, participate, policy, preliminarily, preliminary, protectHytrin, proton, pump, Ranbaxy, reconsideration, Reductil, Reductyl, refused, regulatory, revised, Roxane, shown, Supplemental, Supreme, toMDL, trial, typically, valuation, vitro, volume, Wayne, Western
Removed:
alleged, assumed, Attorney, borrowed, cancelled, Chemical, comprehensive, consolidating, conspired, core, date, declaratory, designated, discriminate, distributed, eligible, entered, extended, favorable, fix, fixed, Flomax, fractional, glucose, hedge, Humira, ii, improper, infringe, injunction, injunctive, institutional, investment, issuance, launch, leader, lieu, Lupron, manage, recipient, reduction, reimbursement, release, reorganized, repayment, replaced, resolution, resulting, retail, retained, retire, retired, ruling, separation, shift, Southern, spinal, stop, subsequent, Synthroid, Takeda, taxable, variability, variable, violation, XL
Filing tables
Filing exhibits
Related press release
ABT similar filings
Filing view
External links